{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:06:54Z","timestamp":1784898414502,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1985,5,1]],"date-time":"1985-05-01T00:00:00Z","timestamp":483753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1985,5]]},"DOI":"10.1007\/bf01733669","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T07:23:25Z","timestamp":1118647405000},"page":"428-432","source":"Crossref","is-referenced-by-count":6,"title":["Nutzen und Risiko von hochdosiertem Metoclopramid im Vergleich zu hochdosiertem Haloperidol oder Triflupromazin bei cisplatin-induziertem Erbrechen","The benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced emesis"],"prefix":"10.1007","volume":"63","author":[{"given":"R.","family":"Saller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hellenbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"Suppl 1","key":"BF01733669_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00003495-198300251-00004","volume":"25","author":"OE Akwari","year":"1983","unstructured":"Akwari OE (1983) The gastrointestinal tract in chemotherapy-induced emesis. Drugs 25(Suppl 1):18\u201334","journal-title":"Drugs"},{"key":"BF01733669_CR2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7326\/0003-4819-98-1-86","volume":"98","author":"R Albibi","year":"1983","unstructured":"Albibi R, McCallum RW (1983) Metoclopramide: Pharmacology and clinical application. Ann Int Med 98:86\u201395","journal-title":"Ann Int Med"},{"key":"BF01733669_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00003088-198308060-00003","volume":"8","author":"DN Bateman","year":"1983","unstructured":"Bateman DN (1983) Clinical pharmacokinetics of metoclopramide. Clin Pharmacokin 8:523\u2013529","journal-title":"Clin Pharmacokin"},{"issue":"Suppl 1","key":"BF01733669_CR4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00003495-198300251-00003","volume":"25","author":"HL Borison","year":"1983","unstructured":"Borison HL, McCarthy LE (1983) Neuropharmacology of chemotherapy-induced emesis. Drugs 25(Suppl 1):8\u201317","journal-title":"Drugs"},{"key":"BF01733669_CR5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/bja\/50.3.295","volume":"50","author":"JG Brock-Utne","year":"1978","unstructured":"Brock-Utne JG, Rubin J, Welman S, Dimopoulos GE, Moshal MG, Downing JW (1978) The action of commonly used antiemetics on the lower oesophageal sphincter. J Anaesth 50:295\u2013298","journal-title":"J Anaesth"},{"key":"BF01733669_CR6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2307\/3001547","volume":"8","author":"J Bross","year":"1952","unstructured":"Bross J (1952) Sequential medical plans. Biometrics 8:188\u2013205","journal-title":"Biometrics"},{"key":"BF01733669_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-3-642-68474-6_9","volume-title":"Mediators and drugs in gastrointestinal motility II","author":"EE Daniel","year":"1982","unstructured":"Daniel EE (1982) Pharmacology of adrenergic, cholinergic, and drugs acting on other receptors in gastrointestinal muscle. In: Bertaccini G (ed) Mediators and drugs in gastrointestinal motility II. Springer, Berlin Heidelberg New York, pp 249\u2013322"},{"key":"BF01733669_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1445-5994.1983.tb04550.x","volume":"13","author":"ML Friedlander","year":"1983","unstructured":"Friedlander ML, Kearsley JA, Sims K, Coates A, Hedley D, Raghavan D, Fox RM, Tallersall MHN (1983) Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy. Austr N Z J Med 13:53\u201356","journal-title":"Austr N Z J Med"},{"key":"BF01733669_CR9","first-page":"135","volume":"302","author":"RJ Gralla","year":"1981","unstructured":"Gralla RJ, Ittri LM, Pisko S, Squillante AE, Kelson DP, Braun DW, Brodin LA, Braun TJ, Young CW (1981) Antiemetic efficacy of high-dose metoclopromide: Randomized trials with placebo and prochlorperacine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 302:135\u2013138","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"BF01733669_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-198300251-00007","volume":"25","author":"RJ Gralla","year":"1983","unstructured":"Gralla RJ (1983) Metoclopramide, a review of antiemetic trials. Drugs 25(Suppl 1):63\u201373","journal-title":"Drugs"},{"key":"BF01733669_CR11","unstructured":"Grunberg SM, Gala KV, Lampenfeld M, Jamin D, Johnson K, Cariffe P (1983) Comparison of the antiemetic effect of high-dose intravenous metoclopramide (M) and high-dose haldol (H) in a randomized double-blind crossover study. Proc Amer Soc Clin Oncol T 85"},{"key":"BF01733669_CR12","first-page":"61","volume":"23","author":"JA Gylys","year":"1979","unstructured":"Gylys JA, Doran KM, Buyniski JP (1979) Antagonism of cisplatin induced emesis in the dog. Res Comm Chem Pathol Pharmacol 23:61\u201368","journal-title":"Res Comm Chem Pathol Pharmacol"},{"key":"BF01733669_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93\u201396","journal-title":"Nature"},{"issue":"Suppl 1","key":"BF01733669_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-198300251-00009","volume":"25","author":"JW Laszlo","year":"1983","unstructured":"Laszlo JW (1983) Closing remarks: selecting an antiemetic for the individual patient. Drugs 25(Suppl 1):81\u201383","journal-title":"Drugs"},{"key":"BF01733669_CR15","first-page":"93","volume-title":"Antiemetics and cancer chemotherapy","author":"VS Lucas","year":"1983","unstructured":"Lucas VS (1983) Phenothiazines as antiemetics. In: Laszlo J (ed) Antiemetics and cancer chemotherapy. Williams and Wilkins, Baltimore-London, pp 93\u2013107"},{"key":"BF01733669_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/j.1552-4604.1975.tb02368.x","volume":"15","author":"B Nakra","year":"1975","unstructured":"Nakra B, Bond AJ, Lader MH (1975) Comparative psychotropic effects of metoclopramide and prochlorperazine in normal subjects. J Clin Pharmacol 15:449\u2013454","journal-title":"J Clin Pharmacol"},{"key":"BF01733669_CR17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/1097-0142(19810315)47:6<1439::AID-CNCR2820470633>3.0.CO;2-#","volume":"47","author":"JA Neidhart","year":"1981","unstructured":"Neidhart JA, Gagen M, Young D, Wilson HE (1981) Specific antiemetics for cancer chemotherapeutic agents: Haloperidol versus benzquinamide. Cancer 47:1439\u20131443","journal-title":"Cancer"},{"key":"BF01733669_CR18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(82)92206-1","volume":"I","author":"SJ Peroutka","year":"1982","unstructured":"Peroutka SJ, Snyder SH (1982) Antiemetics: Neurotransmitter receptor binding predicts therapeutic actions. Lancet I:658\u2013659","journal-title":"Lancet"},{"key":"BF01733669_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/clpt.1985.9","volume":"37","author":"R Saller","year":"1985","unstructured":"Saller R, Hellenbrecht D, Briemann L, Hellstern A, Hess, Mitrou P, Hodgson M, Achtert G, Brockmann P, Hausleiter HJ (1985) Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis. Clin Pharmacol Ther 37:43\u201347","journal-title":"Clin Pharmacol Ther"},{"key":"BF01733669_CR20","first-page":"230","volume":"33","author":"P Seeman","year":"1981","unstructured":"Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 33:230\u2013313","journal-title":"Pharmacol Rev"},{"issue":"Suppl 1","key":"BF01733669_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-198300251-00005","volume":"25","author":"G Wampler","year":"1983","unstructured":"Wampler G (1983) The pharmacology and clinical effectiveness of pheothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25(Suppl 1):35\u201351","journal-title":"Drugs"},{"key":"BF01733669_CR22","unstructured":"Weber E (1972) Grundriss der biologischen Statistik. Fischer, Stuttgart."}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01733669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01733669\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01733669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T10:11:23Z","timestamp":1557310283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01733669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,5]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1985,5]]}},"alternative-id":["BF01733669"],"URL":"https:\/\/doi.org\/10.1007\/bf01733669","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,5]]}}}